Our Firm is representing hundreds of women in the Southern District of West Virginia who allegedly suffered life-changing vaginal mesh complications due to products manufactured by C.R. Bard and other companies.
New York, NY (PRWEB) July 07, 2014
Transvaginal Mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) filed against C.R. Bard, Inc. continue to move forward in the U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to an Order dated July 2, 2014, the Court will hear Oral Arguments on a Plaintiffs’ Motion to Amend Pre-Trial Order No. 121 (Stipulated Evidence Preservation Protocol for Potential Trial Selection Cases) on Wednesday, July 9th. The telephonic hearing will take place at 11:45 a.m. before the U.S. Magistrate Judge. (MDL No. 2187)
“Our Firm is representing hundreds of women in the Southern District of West Virginia who allegedly suffered life-changing vaginal mesh complications due to products manufactured by C.R. Bard and other companies. We are pleased to see this proceeding moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free transvaginal mesh lawsuit consultations to women who allegedly suffered serious complications following implantation of devices manufactured by C.R. Bard, Inc., as well as American Medical Systems, Inc., Ethicon, Inc. and Boston Scientific Corp.
Transvaginal Mesh Lawsuits
Court documents indicate that nearly 9,000 transvaginal mesh lawsuits are pending against C.R. Bard in The Southern District of West Virginia, where Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee. All of the complaints similarly allege that the company’s surgical mesh products used in the treatment of pelvic organ prolapse and stress urinary incontinence caused recipients to suffer mesh erosion, chronic pain, scarring, infections, organ damage, and other serious vaginal mesh complications. The lawsuits further allege that these devices were defectively designed and manufactured, and that premarket testing of the products was not adequate to ensure their safety and effectiveness.
According to court records, nearly 60,000 transvaginal mesh lawsuits that make similar allegations have been filed in the Southern District of West Virginia against a number of medical device manufacturers. Mr. Grand is also a member of the Plaintiffs’ Steering Committees in proceedings involving American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and Ethicon, Inc. (MDL No. 2327).
Mr. Grand is also serving as Co-Liaison Counsel in two multicounty litigations underway in New Jersey Superior Court for transvaginal mesh lawsuits involving products marketed by C.R. Bard and Ethicon. He was also a member of the Plaintiff’s trial team on the first Ethicon trial in that proceeding, which ended in March 2013 with a jury awarding $11 million in compensatory and punitive damages to a woman who suffered vaginal mesh complications related to the Ethicon Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Women who were allegedly harmed by transvaginal mesh may be entitled to compensation for the financial, physical and emotional damages related to their vaginal mesh complications. To learn more about filing a transvaginal mesh lawsuit, please visit Bernstein Liebhard LLP's website or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To arrange for a free, no obligation case review, please contact the Firm today at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP